spacer
home > news > detailed info
INDUSTRY NEWS AND PRESS RELEASES

Gerresheimer at Pharmapack: With the g guide the optimum solution for biotech and pharma

Gerresheimer AG



Düsseldorf, Germany. April 2022.
Which packaging or delivery solution is best suited to the respective active ingredient? In addition to Gerresheimer's experts, the g guide has recently been answering this important question for customers and interested parties. At Pharmapack in Paris on May 18 and 19, Gerresheimer will demonstrate the g guide for the first time at a trade fair on Stand B60/B64.

Through g guide Gerresheimer creates more direct access to its diverse product solutions for its customers and partners in the pharma, biopharma, and veterinary sectors. A specially developed algorithm is used to filter the more than 1500 products from the company's diverse pharma product areas based on user input. The product selector g guide combines the modern use of online advice with the highly valued expertise of the Gerresheimer team. The digital tool guides users intuitively to a selection of suitable product solutions from the Gerresheimer portfolio based on six targeted questions relating to the medicinal product to be packaged and its specific sensitivities.



The company's extensive portfolio includes solutions for the entire world of human and veterinary medicine. The spectrum ranges from cough syrup bottles and ready-to-fill syringes to drug delivery devices for chronically ill patients such as diabetics or asthmatics.

SensAIR, the platform for an innovative on-body drug delivery device for drugs with higher viscosity

With SensAIR Gerresheimer presents for the first time an innovative platform for an on-body drug delivery device for drugs with higher viscosity, such as monoclonal antibodies (mAb). The aim is to offer patients the best possible support in the subcutaneous delivery of large-volume biologics. The device can be adapted to many drugs of different viscosity and different requirements. Together with Gerresheimer's One-Stop-Shop quality promise, which comprises a solution from cartridge to drug delivery device from a single source, SensAIR enables the safe and optimized delivery of biologics.

Gx InnoSafe protects against unintentional needlestick injuries and is easy to fill

Nurses are among the occupational groups with the most frequent cuts and puncture wounds. This can lead to infection with dangerous pathogens such as hepatitis B and C viruses or HIV. The Gx InnoSafe safety syringe is the first syringe on the market with a passive needle protection system. Its function prevents anyone from accidentally injuring themselves through an unintentional needle stick on a syringe that has already been used, as the needle is fixed in a sleeve after use. In addition to these unique safety features, a special feature of the Gx InnoSafe syringe is that it can be processed on all existing filling lines without any additional preparation or conversion steps. Furthermore, it complies with all regulations without any additional investment.

Gx RTF Vials - The solution for clinical trials and industrialization: Depyrogenated, sterile and ready-to-use vials for injectables of highest quality

The Gx RTF injection vials are made of borosilicate glass type I and meet all common requirements of the applicable ISO standards and pharmacopoeias (USP and Ph. Eur.). They are formed in accordance with cGMP, washed in a clean room, packed in trays or nests and tubs and sterilized. Gerresheimer RTF vials are also supplied in the familiar Ompi EZ-fill packaging format. This means they are ready for the next process steps in filling.

Injection and infusion bottles made of type II glass: the solution for parenteral applications

Gerresheimer also specializes in the production of pharmaceutical containers made of Type II glass. Both the smallest bottle sizes for injections and typical infusion bottles with larger volumes can be treated with a special tempering method. Ensuring the glass quality and the hydrolytic resistance of the type II glass are the top priorities here. The new furnace technology, the expansion of the clean room, and the automation and digitalization of the testing and packaging facilities have enabled the company to secure its leading position.

EcoLine for the sustainable development of plastic containers

With EcoLine, Gerresheimer demonstrates criteria in the development and production of its well-known plastic container series for solid and liquid medications which play an important role in the design of sustainable packaging solutions and thus contribute to greater environmental compatibility. The concept includes the criteria of weight, volume, material, and recyclability. EcoLine can be applied to the development of all existing Gerresheimer product families such as Duma, Triveni, the dropper bottles and to PET bottles.

Product information at the stand for sustainable download

Gerresheimer is serious about sustainability and this year for the first time will offer its information at the stand for direct download via URL codes.

Further information about Gerresheimer products on the Internet:




Download information about diagnostics and medical services


phone +49-(0)211/61 81-00
email info@gerresheimer.com
web www.gerresheimer.com
email Klaus-Bungert-Str. 4, 40468 Duesseldorf, Germany
 
Print this page
Send to a friend
   
spacer
News and Press Releases

FlyPharma Conference Europe 2022 Shares the Latest Supply Chain Challenges and Advice for Better Industry Collaboration

On 20-21 September 2022, the FlyPharma Conference Europe made a welcome return as a live, in-person event. The conference was warmly received by its delegates and declared a resounding success, with some familiar faces from previous events and many new ones in attendance across the two days.
More info >>


White Papers

Data Technology as a Catalyst for Growth in the Life Sciences

Aigenpulse

The life sciences industry is changing at a rapid pace. The need to develop the next blockbuster is pushing current technologies and methodologies to the limit. Scientific advancement over the last decades was embossed with giant leaps in knowledge, however, the new reality is that smaller incremental gains need to be carved out with ever increasing investments. In order to survive, progress and prosper in this new reality, a holistic approach to getting the most of research data is crucial. In fact, it will likely be the difference of being in existence in 5-10 years or not. For those bold enough to step into an area they are unfamiliar with, huge rewards are waiting.
More info >>

 
©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement